Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-29

Clinical Trial Update: Immune Reconstitution of Immunosuppressed Sepsis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating immune reconstitution in immunosuppressed sepsis patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Limoges | Conditions: Severe Sepsis With Septic Shock | Phase 2 | Status: TERMINATED